References
- MelgaardLHersiniKJGazeraniPPetersenLJRetrodialysis: a review of experimental and clinical applications of reverse microdialysis in the skinSkin Pharmacol Physiol20132616017423751503
- de LangeECde BoerAGBreimerDDMethodological issues in microdialysis sampling for pharmacokinetic studiesAdv Drug Deliv Rev20004512514811108971
- ElmquistWFSawchukRJApplication of microdialysis in pharmacokinetic studiesPharm Res1997142672889098867
- StåhleLArnerPUngerstedtUDrug distribution studies with microdialysis. III: Extracellular concentration of caffeine in adipose tissue in manLife Sci199149185318581943489
- ChaurasiaCSMüllerMBashawEDAAPS-FDA workshop white paper: microdialysis principles, application, and regulatory perspectivesJ Clin Pharmacol20074758960317442685
- BarbhaiyaRHForgueSTShyuWCPappEAPittmanKAHigh-pressure liquid chromatographic analysis of BMY-28142 in plasma and urineAntimicrob Agents Chemother19873155593566239
- HagiharaMSutherlandCNicolauDPDevelopment of HPLC methods for the determination of vancomycin in human plasma, mouse serum and bronchoalveolar lavage fluidJ Chromatogr Sci20135120120722851425
- KimMKCapitanoBMattoesHMPharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactamPharmacotherapy20022256957712013355
- WiskirchenDECrandonJLFurtadoGHWilliamsGNicolauDPIn vivo efficacy of a human-simulated regimen of ceftaroline combined with NXL104 against extended-spectrum-beta-lactamase (ESBL)-producing and non-ESBL-producing EnterobacteriaceaeAntimicrob Agents Chemother2011553220322521518838
- JoukhadarCMüllerMMicrodialysis: current applications in clinical pharmacokinetic studies and its potential role in the futureClin Pharmacokinet20054489591316122279
- Infectious Diseases Society of AmericaGuidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumoniaAm J Respir Crit Care Med200517138841615699079
- KlibanovOMRaaschRHRubleinJCSingle versus combined antibiotic therapy for gram-negative infectionsAnn Pharmacother20043833233714742774
- Infectious Diseases Society of AmericaThe 10 × ’20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020Clin Infect Dis2010501081108320214473
- BoucherHWTalbotGHBenjaminDKJr10 × ’20 Progress-development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaClin Infect Dis2013561685169423599308